Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Dyadic International (DYAI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 111,927
  • Shares Outstanding, K 26,713
  • Annual Sales, $ 760 K
  • Annual Income, $ -2,140 K
  • 60-Month Beta 0.30
  • Price/Sales 75.60
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.07
  • Growth Rate Est. (year over year) +1,427,242.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.15 +31.43%
on 04/18/19
4.87 -14.99%
on 05/10/19
+0.74 (+21.76%)
since 04/17/19
3-Month
2.30 +80.00%
on 02/20/19
4.87 -14.99%
on 05/10/19
+1.84 (+80.00%)
since 02/15/19
52-Week
1.40 +195.71%
on 08/27/18
4.87 -14.99%
on 05/10/19
+2.64 (+176.00%)
since 05/17/18

Most Recent Stories

More News
Dyadic to Present at the 20th Annual B. Riley FBR Investor Conference and Upcoming Industry Events

JUPITER, FL / ACCESSWIRE / May 17, 2019 / Dyadic International, Inc. (the ''Company'') (NASDAQ: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression...

DYAI : 4.14 (-1.19%)
Dyadic Reports First Quarter 2019 Financial Results and Recent Developments

Dyadic International, Inc. ("Dyadic") (NASDAQ: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to speed up the development, lower...

FSNN : 0.0870 (-3.33%)
DYAI : 4.14 (-1.19%)
Dyadic and Serum Institute of India to Develop and Manufacture Globally Affordable and Accessible Antibody Products and Vaccines

PUNE, INDIA and JUPITER, FL / ACCESSWIRE / May 8, 2019 / Dyadic International, Inc. (''Dyadic'') (NASDAQ: DYAI), a global biotechnology company focused on further improving and applying its proprietary...

DYAI : 4.14 (-1.19%)
New Gene Therapies Hold Out Promise for Patients

Gene therapies are gaining growing attention within the medical sector.

TROV : 3.08 (-2.53%)
ONCE : 107.64 (-0.76%)
NVS : 82.70 (+0.30%)
DYAI : 4.14 (-1.19%)
Dyadic Announces Sub-Licensing Agreement with Alphazyme

JUPITER, FL / ACCESSWIRE / May 6, 2019 / Dyadic International, Inc. ("Dyadic") (NASDAQ: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression...

DYAI : 4.14 (-1.19%)
Dyadic to Report First Quarter 2019 Financial Results on Thursday, May 9, 2019

JUPITER, FL / ACCESSWIRE / April 25, 2019 / Dyadic International, Inc. ("Dyadic") (NASDAQ: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression...

DYAI : 4.14 (-1.19%)
Dyadic Announces Uplisting to the Nasdaq Capital Market

JUPITER, FL / ACCESSWIRE / April 15, 2019 / Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression...

DYAI : 4.14 (-1.19%)
OTC Company Investor Presentations Now Available for On-Demand Viewing

Virtual Investor Conferences, the leading proprietary investor conference series, announced that the presentations from the April 4th, 2019 conference are now available for on-demand viewing at VirtualInvestorConferences.com....

PYR.VN : 0.600 (unch)
SMID : 8.8500 (unch)
FLY.VN : 1.590 (+1.92%)
AXV.VN : 0.890 (+1.14%)
DYAI : 4.14 (-1.19%)
BFGC : 0.1500 (-11.76%)
WDLF : 0.1200 (-13.29%)
Dyadic International to Webcast, Live, at VirtualInvestorConferences.com April 4th

Dyadic International, Inc. (the "Company") (OTCQX: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 expression system to speed up the development, lower...

DYAI : 4.14 (-1.19%)
Live Investor Conference & Webinar April 4th

Virtual Investor Conferences today announced the agenda for the upcoming Virtual lnvestor Conference, the leading proprietary investor conference series. Individual investors, institutional investors,...

PYR.VN : 0.600 (unch)
SMID : 8.8500 (unch)
FLY.VN : 1.590 (+1.92%)
AXV.VN : 0.890 (+1.14%)
DYAI : 4.14 (-1.19%)
WDLF : 0.1200 (-13.29%)
BFGC : 0.1500 (-11.76%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

See More Share

Trade DYAI with:

Business Summary

Dyadic International, Inc. is a leading genomics company with the groundbreaking technology that brings nature to the marketplace. Dyadic is poised to become a global leader in proteomics through the discovery, development, and manufacturing of novel products derived from the DNA of complex living organisms...

See More

Key Turning Points

2nd Resistance Point 4.24
1st Resistance Point 4.19
Last Price 4.14
1st Support Level 4.10
2nd Support Level 4.06

See More

52-Week High 4.87
Last Price 4.14
Fibonacci 61.8% 3.54
Fibonacci 50% 3.13
Fibonacci 38.2% 2.73
52-Week Low 1.40

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar